EA201300314A8 - Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство - Google Patents
Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средствоInfo
- Publication number
- EA201300314A8 EA201300314A8 EA201300314A EA201300314A EA201300314A8 EA 201300314 A8 EA201300314 A8 EA 201300314A8 EA 201300314 A EA201300314 A EA 201300314A EA 201300314 A EA201300314 A EA 201300314A EA 201300314 A8 EA201300314 A8 EA 201300314A8
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- medicines
- treatment
- compositions
- dissolved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к композиции с пролонгированной кинетикой высвобождения терапевтически эффективного количества лекарственного агента, предназначенной для лечения заболеваний или патологических состояний глаз у субъекта, нуждающегося в таком лечении; при этом указанная композиция представляет собой эмульсию типа "вода в масле", содержащую масляную фазу, липофильный сурфактант, растворенный в масляной фазе, а также водную фазу, растворенную в масляной фазе, и гидрофильный лекарственный агент, растворенный в водной дисперсной фазе. При этом указанная композиция может вводиться интраокулярно, поскольку имеет плотность менее 1. Изобретение также относится к фармацевтической композиции или лекарственному средству, содержащему указанную композицию, а также к способу лечения состояния или заболевания глаз, заключающемуся во введении терапевтически эффективного количества указанной композиции, и к устройству, содержащему указанную композицию.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10175337.4A EP2425814B1 (en) | 2010-09-03 | 2010-09-03 | A water-in-oil type emulsion for treating a disease of the eye |
| US12/875,805 US20120058187A1 (en) | 2010-09-03 | 2010-09-03 | Water-in-oil type emulsion for treating a disease of the eye |
| PCT/EP2011/065236 WO2012028733A1 (en) | 2010-09-03 | 2011-09-02 | A water-in-oil type emulsion for treating a disease of the eye |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EA201300314A1 EA201300314A1 (ru) | 2013-11-29 |
| EA201300314A8 true EA201300314A8 (ru) | 2017-08-31 |
| EA028375B1 EA028375B1 (ru) | 2017-11-30 |
Family
ID=45772196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201300314A EA028375B1 (ru) | 2010-09-03 | 2011-09-02 | Композиция в виде эмульсии типа "вода-в-масле" для интраокулярного введения |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2611414B1 (ru) |
| JP (1) | JP5829685B2 (ru) |
| KR (1) | KR101777824B1 (ru) |
| CN (1) | CN103140216B (ru) |
| AU (1) | AU2011298298B2 (ru) |
| BR (1) | BR112013004570A2 (ru) |
| CA (1) | CA2809460C (ru) |
| EA (1) | EA028375B1 (ru) |
| ES (1) | ES2524580T3 (ru) |
| GE (1) | GEP201706606B (ru) |
| HK (1) | HK1186660A1 (ru) |
| MX (1) | MX2013002115A (ru) |
| MY (1) | MY157513A (ru) |
| NZ (1) | NZ607103A (ru) |
| SG (1) | SG188272A1 (ru) |
| WO (1) | WO2012028733A1 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2633324B1 (en) | 2010-10-29 | 2018-11-21 | Cohesive Technologies Inc. | Lc-ms configuration for purification and detection of analytes having a broad range of hydrophobicities |
| TW201609145A (zh) * | 2013-12-25 | 2016-03-16 | 參天製藥股份有限公司 | 注射劑及形成緩釋（ｄｅｐｏｔ）之方法 |
| EA035620B1 (ru) | 2014-08-11 | 2020-07-16 | Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж | Способы и композиция для лечения или профилактики катаракты |
| WO2016071515A1 (en) * | 2014-11-07 | 2016-05-12 | Sigmoid Pharma Limited | Compositions comprising cyclosporin |
| CN109260458B (zh) * | 2017-07-18 | 2022-03-18 | 百捷生物科技有限公司 | 胶原蛋白植入物在制备青光眼手术辅助复原物中的用途 |
| KR102048940B1 (ko) | 2017-12-06 | 2019-11-26 | 주식회사 커스토메이드 | 케이블 가이드가 구비된 케이블 피딩장치 |
| CN108283622A (zh) * | 2018-04-03 | 2018-07-17 | 广州君博医药科技有限公司 | 一种缓释型利奈唑胺眼用药物及其制备方法 |
| KR20210003877A (ko) * | 2018-05-01 | 2021-01-12 | 치비 인코포레이티드 | 약제를 눈에 비침습적으로 지속 전달하기 위한 액체 데포 |
| US20240180865A1 (en) * | 2021-04-08 | 2024-06-06 | Tionlab Therapeutics | Sustained-release lipid pre-concentrate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
| US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
| WO2003075885A1 (fr) * | 2002-03-12 | 2003-09-18 | Ethypharm | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
| US20090082321A1 (en) | 2007-09-21 | 2009-03-26 | Allergan, Inc. | Steroid containing drug delivery systems |
| EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
| US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
| BRPI0817524A2 (pt) | 2007-10-02 | 2017-05-02 | Potentia Pharmaceuticals Inc | liberação prolongada de análogos de compstatina provenientes de géis |
-
2011
- 2011-09-02 MX MX2013002115A patent/MX2013002115A/es active IP Right Grant
- 2011-09-02 ES ES11749460.9T patent/ES2524580T3/es active Active
- 2011-09-02 EA EA201300314A patent/EA028375B1/ru not_active IP Right Cessation
- 2011-09-02 EP EP11749460.9A patent/EP2611414B1/en not_active Not-in-force
- 2011-09-02 CA CA2809460A patent/CA2809460C/en not_active Expired - Fee Related
- 2011-09-02 SG SG2013013321A patent/SG188272A1/en unknown
- 2011-09-02 BR BR112013004570A patent/BR112013004570A2/pt not_active Application Discontinuation
- 2011-09-02 GE GEAP201113046A patent/GEP201706606B/en unknown
- 2011-09-02 KR KR1020137008605A patent/KR101777824B1/ko active IP Right Grant
- 2011-09-02 JP JP2013526494A patent/JP5829685B2/ja not_active Expired - Fee Related
- 2011-09-02 MY MYPI2013000613A patent/MY157513A/en unknown
- 2011-09-02 AU AU2011298298A patent/AU2011298298B2/en not_active Ceased
- 2011-09-02 WO PCT/EP2011/065236 patent/WO2012028733A1/en active Application Filing
- 2011-09-02 CN CN201180042563.1A patent/CN103140216B/zh not_active Expired - Fee Related
- 2011-09-02 NZ NZ607103A patent/NZ607103A/en not_active IP Right Cessation
-
2013
- 2013-12-20 HK HK13114128.1A patent/HK1186660A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MY157513A (en) | 2016-06-15 |
| AU2011298298A1 (en) | 2013-03-14 |
| WO2012028733A1 (en) | 2012-03-08 |
| BR112013004570A2 (pt) | 2016-09-06 |
| EP2611414A1 (en) | 2013-07-10 |
| JP5829685B2 (ja) | 2015-12-09 |
| MX2013002115A (es) | 2013-06-28 |
| CN103140216A (zh) | 2013-06-05 |
| JP2013536829A (ja) | 2013-09-26 |
| KR101777824B1 (ko) | 2017-09-26 |
| EP2611414B1 (en) | 2014-11-12 |
| EA201300314A1 (ru) | 2013-11-29 |
| HK1186660A1 (en) | 2014-03-21 |
| CA2809460C (en) | 2018-12-11 |
| EA028375B1 (ru) | 2017-11-30 |
| CA2809460A1 (en) | 2012-03-08 |
| KR20130101051A (ko) | 2013-09-12 |
| SG188272A1 (en) | 2013-04-30 |
| GEP201706606B (en) | 2017-01-25 |
| AU2011298298B2 (en) | 2016-04-21 |
| CN103140216B (zh) | 2015-07-15 |
| NZ607103A (en) | 2015-09-25 |
| ES2524580T3 (es) | 2014-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201300314A1 (ru) | Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство | |
| SMT201300101B (it) | Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio | |
| ES2829904T3 (es) | Composiciones de solución sólida y uso en dolor intenso | |
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| ES2830447T3 (es) | Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación | |
| WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
| MX348705B (es) | Composiciones farmacéuticas y métodos de administración relacionados. | |
| BRPI0819081A8 (pt) | Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento | |
| RU2677346C2 (ru) | Композиции и способы для лечения сильной боли | |
| RU2016105581A (ru) | Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться | |
| EA201792559A1 (ru) | Фармацевтические композиции для местного применения | |
| BRPI0821683B8 (pt) | uso de um agonista parassimpático e de um antagonista simpático ou um agonista simpático para tratar presbiopia, miopia, hipermetropia, emetropia e/ou astigmatismo, e/ou para melhorar a visão noturna ou de baixa luz | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EA201490279A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| BR112016015763B8 (pt) | preparação farmacêutica incluindo composto de ácido piridilaminocético, e, uso da mesma | |
| RU2761967C2 (ru) | Способ лечения, включающий пероральное или желудочное введение эдаравона | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| RU2013123796A (ru) | Способ лечения болезни дюпюитрена | |
| RU2016103098A (ru) | Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii | |
| AU2014216273A1 (en) | Topical ocular analgesic agents | |
| RU2022102195A (ru) | Новые способы лечения бокового амиотрофического склероза | |
| ES2779525T3 (es) | Composición que comprende un éster de alfa-tocoferol para prevención y tratamiento de rinitis alérgica | |
| HRP20230634T1 (hr) | Pripravci za liječenje oftalmoloških stanja |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |